Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Debt Ratio (2020 - 2023)

Updated

Century Therapeutics' Debt Ratio was 0.02 in Q1 2023, up 24.0% from 0.02 a year earlier and up 7.2% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Debt Ratio (2020 - 2023) Analysis & Trends

From Q4 2020 onward, Century Therapeutics has reported Debt Ratio for 7 quarters.

  • In earlier years, Debt Ratio was 0.02 in FY2021 (-74.8%) and 0.09 in FY2020.
  • The Q1 2023 figure marks the highest quarterly Debt Ratio since Q4 2021.
  • Per Business Quant data, IPSC's Debt Ratio in the three quarters before Q1 2023 was 0.02 (Q4 2022), 0.02 (Q3 2022) and 0.02 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Century Therapeutics 301.51 Mn -202.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.02
Dec 31, 2022 0.02
Sep 30, 2022 0.02
Jun 30, 2022 0.02
Mar 31, 2022 0.02
Dec 31, 2021 0.02
Dec 31, 2020 0.09
API Access

Century Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=IPSC&period=max&api_key=YOUR_API_KEY